Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AZATHIOPRINE Cause Second primary malignancy? 5 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Second primary malignancy have been filed in association with AZATHIOPRINE (AZATHIOPRINE). This represents 0.0% of all adverse event reports for AZATHIOPRINE.

5
Reports of Second primary malignancy with AZATHIOPRINE
0.0%
of all AZATHIOPRINE reports
3
Deaths
3
Hospitalizations

How Dangerous Is Second primary malignancy From AZATHIOPRINE?

Of the 5 reports, 3 (60.0%) resulted in death, 3 (60.0%) required hospitalization, and 3 (60.0%) were considered life-threatening.

Is Second primary malignancy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AZATHIOPRINE. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does AZATHIOPRINE Cause?

Drug ineffective (8,076) Off label use (5,358) Drug intolerance (3,392) Condition aggravated (2,832) Rheumatoid arthritis (2,746) Treatment failure (2,483) Arthralgia (2,427) Drug hypersensitivity (2,421) Nausea (2,178) Pneumonia (2,157)

What Other Drugs Cause Second primary malignancy?

CYCLOPHOSPHAMIDE (1,247) DOXORUBICIN (1,151) VINCRISTINE (908) IMATINIB (763) PALBOCICLIB (658) RITUXIMAB (646) RUXOLITINIB (611) ETOPOSIDE (573) PREDNISONE (517) OCTREOTIDE (496)

Which AZATHIOPRINE Alternatives Have Lower Second primary malignancy Risk?

AZATHIOPRINE vs AZD-1222 AZATHIOPRINE vs AZELAIC ACID AZATHIOPRINE vs AZELASTINE AZATHIOPRINE vs AZELASTINE\FLUTICASONE AZATHIOPRINE vs AZELNIDIPINE

Related Pages

AZATHIOPRINE Full Profile All Second primary malignancy Reports All Drugs Causing Second primary malignancy AZATHIOPRINE Demographics